In 2022, Eli Lilly introduced Mounjaro (tirzepatide), a dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) receptor agonist, as a direct competitor of Ozempic
[BIG CTA GRAPHIC/BUTTON HERE] Why Breakfast Can Feel Hard on a GLP-1 GLP-1 medications slow down digestion
Can I keep lifting and doing high intensity workouts on Willow GLP-1
Diplopia can be caused by many problems including lens cataracts, corneal infections or scars, hormone problems (eg, Graves disease), diabetes, autoimmune diseases (eg, multiple sclerosis), stroke, brain tumors, brain trauma, and migraine headaches (Kim 2013
Results vary from person to person, but studies show most patients lose around 15% of their starting body weight over 24 weeks, roughly 30 pounds for a 200-pound person
78.3% were of European ancestry, 12.9% Latino, and 4.2% African American